Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP

Clinical trial NCT00584350 · UNKNOWN

Trial details

NCT number: NCT00584350
Sponsor: Université de Sherbrooke
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Radiographic Contrast Agent Nephropathy Renal Failure Coronary Heart Disease

Start date: 2007-11-01
Primary completion: 2015-12-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.